MBX Biosciences (MBX) PT Raised to $86 at Citizens on 'Good' MBX 4291 Update
Citizens analyst Jonathan Wolleben raised the price target on MBX Biosciences Inc (NASDAQ: MBX) to $86.00 (from $76.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)